Rocket Pharmaceuticals In... (RCKT)
NASDAQ: RCKT
· Real-Time Price · USD
3.04
0.01 (0.33%)
At close: Aug 15, 2025, 3:59 PM
3.02
-0.68%
After-hours: Aug 15, 2025, 07:30 PM EDT
Rocket Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 9.19M | 9.19M | 9.19M | 10.31M | 10.31M | 10.31M | 10.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 7.92M | 7.72M | 6.98M | 12.14M | 11.51M | 10.89M | 10.31M | 6.93M | 6.81M | 6.65M | 6.28M | 7.69M | 6.85M | 5.99M | 5.36M | 2.17M | 1.37M | 674K |
Gross Profit | -3.32M | -3.12M | -2.39M | -1.83M | -1.2M | -581K | n/a | -6.93M | -6.81M | -6.65M | -6.28M | -7.69M | -6.85M | -5.99M | -5.36M | -2.17M | -1.37M | -674K |
Operating Income | -267.65M | -270.22M | -273.2M | -273.79M | -269.8M | -264.84M | -259.66M | -265.46M | -258.52M | -243.97M | -224.34M | -199.59M | -190.75M | -170.59M | -167.25M | -182.15M | -159.9M | -149.41M |
Interest Income | 12.24M | 14.08M | 16.34M | 17.59M | 18.42M | 17.4M | 15.94M | 14.18M | 11.53M | 8.68M | 4.97M | 3.49M | 2.95M | 2.78M | 2.43M | 1.82M | 1.53M | 1.46M |
Pretax Income | -257.3M | -258.03M | -258.75M | -258.08M | -253.26M | -249.31M | -245.59M | -252.66M | -248.51M | -237.22M | -221.86M | -199.39M | -191.75M | -171.87M | -169.07M | -185.74M | -164.7M | -155.22M |
Net Income | -257.3M | -258.03M | -258.75M | -258.08M | -253.26M | -249.31M | -242.2M | -246.91M | -242.03M | -230.93M | -219.38M | -199.26M | -192.36M | -172.29M | -169.07M | -185.74M | -164.7M | -155.22M |
Selling & General & Admin | 105.91M | 107.47M | 100.39M | 96.59M | 88.06M | 78.86M | 73.32M | 70.83M | 67.35M | 62.83M | 58.77M | 51.9M | 46.47M | 42.86M | 41.77M | 37.8M | 33.86M | 31.44M |
Research & Development | 158.27M | 160.41M | 168.22M | 172.61M | 177.14M | 183.73M | 186.34M | 194.63M | 191.17M | 181.15M | 165.57M | 147.69M | 144.29M | 127.73M | 125.48M | 144.35M | 126.03M | 117.97M |
Other Expenses | 3.47M | n/a | n/a | n/a | n/a | n/a | n/a | -500K | -500K | -500K | -500K | -500K | -500K | -500K | n/a | 500K | 500K | 500K |
Operating Expenses | 267.65M | 267.88M | 268.61M | 269.2M | 265.2M | 262.59M | 259.66M | 264.96M | 258.02M | 243.47M | 223.84M | 199.09M | 190.25M | 170.09M | 166.25M | 181.65M | 159.4M | 148.91M |
Interest Expense | 1.89M | 1.89M | 1.89M | 1.88M | 1.88M | 1.88M | 1.88M | 1.87M | 2.02M | 2.42M | 2.99M | 3.79M | 4.44M | 4.56M | 5.25M | 5.9M | 6.83M | 7.76M |
Selling & Marketing Expenses | n/a | -786K | -1.57M | -1.57M | -1.57M | -787K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 267.65M | 270.22M | 273.2M | 273.79M | 269.8M | 264.84M | 259.66M | 264.96M | 258.02M | 243.47M | 223.84M | 199.09M | 190.25M | 170.09M | 166.25M | 181.65M | 159.4M | 148.91M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -3.39M | -5.75M | -6.48M | -6.29M | -2.48M | -122K | 610K | 669K | 251K | 488K | 488K | 237K |
Shares Outstanding (Basic) | 111.02M | 110.09M | 97.53M | 94.16M | 93.75M | 93.55M | 93.34M | 82.64M | 80.47M | 79.45M | 72.89M | 66.22M | 65.48M | 64.51M | 64.47M | 63.83M | 63.06M | 61.57M |
Shares Outstanding (Diluted) | 111.02M | 110.09M | 97.53M | 94.16M | 93.75M | 93.55M | 93.34M | 82.64M | 80.47M | 79.45M | 72.89M | 66.22M | 65.48M | 64.51M | 64.47M | 63.83M | 63.06M | 61.57M |
EPS (Basic) | -2.51 | -2.63 | -2.73 | -2.75 | -2.79 | -2.87 | -2.9 | -3.14 | -3.25 | -3.26 | -3.24 | -3.05 | -2.98 | -2.7 | -2.68 | -3.09 | -2.83 | -2.73 |
EPS (Diluted) | -2.51 | -2.63 | -2.73 | -2.75 | -2.79 | -2.87 | -2.9 | -3.14 | -3.25 | -3.26 | -3.24 | -3.05 | -2.98 | -2.7 | -2.68 | -3.09 | -2.83 | -2.73 |
EBITDA | -245.09M | -246.06M | -247.52M | -246.85M | -242.66M | -239.33M | -236.2M | -244.35M | -240.34M | -229.2M | -214.22M | -190.34M | -183.47M | -163.94M | -160.5M | -178.05M | -156.08M | -146.37M |
EBIT | -255.41M | -256.14M | -256.86M | -256.2M | -251.38M | -247.44M | -243.72M | -251.28M | -246.99M | -235.3M | -219.37M | -196.9M | -188.61M | -168.61M | -164.48M | -179.2M | -157.23M | -146.81M |
Depreciation & Amortization | 10.32M | 10.08M | 9.34M | 9.35M | 8.72M | 8.1M | 7.52M | 6.93M | 6.81M | 6.65M | 6.28M | 7.69M | 6.85M | 5.99M | 5.36M | 2.8M | 2.28M | 1.7M |